Technical Analysis for NVCR - NovoCure Limited

Grade Last Price % Change Price Change
grade C 66.63 5.19% 3.29
NVCR closed down 4.44 percent on Friday, April 3, 2020, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical NVCR trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 5.19%
180 Bearish Setup Bearish Swing Setup 5.19%
Crossed Above 20 DMA Bullish 0.53%
Fell Below 20 DMA Bearish 3.27%
1,2,3 Retracement Bearish Bearish Swing Setup -1.05%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.05%
20 DMA Support Bullish -1.05%
Inside Day Range Contraction -1.05%
Wide Bands Range Expansion -1.05%
Death Cross Bearish -4.87%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

NovoCure Limited develops and commercializes treatment for solid tumor cancers therapy called the tumor treating fields (TTFields). The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. NovoCure Limited also conducts clinical trials for the use of TTFields in brain metastases, advanced non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, as well as in European Union member states, Switzerland, and Japan. NovoCure Limited was founded in 2000 and is based in Saint Helier, Channel Islands.
Medicine Cancer Clinical Medicine Oncology Tumor Non Small Cell Lung Cancer Ovarian Cancer Glioblastoma Pancreatic Cancer Aging Associated Diseases Brain Tumor European Union Solid Tumor Cancers Mesothelioma

Is NVCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 98.84
52 Week Low 41.51
Average Volume 979,235
200-Day Moving Average 78.97
50-Day Moving Average 76.46
20-Day Moving Average 64.82
10-Day Moving Average 64.57
Average True Range 5.76
ADX 32.85
+DI 15.22
-DI 22.07
Chandelier Exit (Long, 3 ATRs ) 58.19
Chandelier Exit (Short, 3 ATRs ) 70.67
Upper Bollinger Band 73.30
Lower Bollinger Band 56.33
Percent B (%b) 0.41
BandWidth 26.18
MACD Line -2.95
MACD Signal Line -3.95
MACD Histogram 1.0026
Fundamentals Value
Market Cap 5.63 Billion
Num Shares 88.9 Million
EPS -1.09
Price-to-Earnings (P/E) Ratio -58.11
Price-to-Sales 13.08
Price-to-Book 13.88
PEG Ratio -0.41
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 67.78
Resistance 3 (R3) 68.09 66.93 67.04
Resistance 2 (R2) 66.93 65.80 66.77 66.79
Resistance 1 (R1) 65.13 65.10 64.55 64.82 66.55
Pivot Point 63.97 63.97 63.68 63.81 63.97
Support 1 (S1) 62.17 62.84 61.59 61.86 60.13
Support 2 (S2) 61.01 62.14 60.85 59.89
Support 3 (S3) 59.21 61.01 59.64
Support 4 (S4) 58.90